Cerity Partners’s Bicycle Therapeutics BCYC Stock Holding History

Cerity Partners’s Portfolio BCYC Stock Details BCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$57.5K	Hold	13,570	–	–	﹤0.01%	3288
2026 Q1	$63K	Buy	13,570 +220	+2%	+$1.26K	﹤0.01%	3079
2025 Q4	$94.5K	Sell	13,350 -1,000	-7%	-$7.37K	﹤0.01%	2756
2025 Q3	$111K	Hold	14,350	–	–	﹤0.01%	2617
2025 Q2	$99.7K	Buy	14,350 +1,000	+7%	+$7.96K	﹤0.01%	2479
2025 Q1	$113K	Buy	+13,350	New	+$157K	﹤0.01%	2308

Other funds holding BCYC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

GSK plc London $602M AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Cerity Partners's BCYC Position: Q2 2026 in Review

Cerity Partners held its Bicycle Therapeutics (BCYC) position steady in Q2 2026 at 13,570 shares worth $57.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3288.

Cerity Partners first reported a position in BCYC in Q1 2025 and has held it in 6 quarters since. The position peaked at $113K in Q1 2025. 103 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

Cerity Partners held 13,570 shares of Bicycle Therapeutics worth $57.5K as of Q2 2026.
Cerity Partners left its Bicycle Therapeutics share count unchanged in Q2 2026.
Bicycle Therapeutics made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #3288 holding.
Cerity Partners first reported a position in Bicycle Therapeutics in Q1 2025 and has held it in 6 quarters since.
Cerity Partners's Bicycle Therapeutics position peaked at $113K in Q1 2025.
103 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.